Centers | ||
|
|
|
test | EU-OPENSCREEN | Therapeutic Accelerator Program (TAP) |
sfgd |
EU-OPENSCREEN is a multinational, not-for-profit initiative, which
integrates high-capacity screening platforms and chemistry groups across
Europe. The aim of this initiative is to support individual scientists
interested in chemical biology... |
Test |
Partnerships |
Events |
Jobs |
Pharma and Academia Consortium Partner to Develop New Drugs in EuropeA consortium of academic institutes from Germany, Britain, Netherlands and Denmark partner with a group of leading pharmaceutical companies which include AstraZeneca, Sanofi, Bayer, UCB , Lundbeck , Merck KGaA, and Janssen which is a JNJ... View all Sanofi and Joslin Diabetes Center to Develop New Drugs for Diabetic CareJoslin Diabetes Center a teaching and research affiliate of Harvard Medical School and Sanofi have entered into a partnership agreement to develop new drugs to treat diabetes. Under this collaboration, Sanofi will have the right to commercialize... View all Argenta and ANTABIO Announce Drug Discovery CollaborationArgenta, a Galapagos NV (Euronext: GLPG) company that provides drug discovery services from target validation to proof of concept, announced today that it has achieved a milestone with its collaboration partner Antabio in an anti-bacterial drug... View all |
The ABE 2023 Annual Meeting will take place on April 30-May 4 at the Kiawah Island Resort in...  On behalf of the American Society for Reproductive Immunology, it is with great enthusiasm that we... |
Post-doctoral Research Fellow in Gene Therapy
id: 22560 Postdoctoral Fellowship in Metastatic Cancer Research
id: 22561 Postdoctoral Fellowship in Obesity and Metabolism Research
id: 22564 Postdoc
id: 22536 |
